Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents

Transplantation

Volumn 97, Issue 3, 2014, Pages 294-300

  Shin, Bong Ha ^a   Ge, Shili ^a   Mirocha, James ^c   Karasyov, Artur ^a   Vo, Ashley ^b   Jordan, Stanley C ^b   Toyoda, Mieko ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Biostatistics Core   (United States)

Author keywords

Antibody dependent cellular cytotoxicity; CD107a; IFN ; Immunosuppressive drugs; NK cells

Indexed keywords

ANTIBODIES; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD56; CALCINEURIN; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MYCOPHENOLIC ACID; RISK; SIROLIMUS; TACROLIMUS;

EID: 84894063916     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000438636.52085.50     Document Type: Article

References (45)

1. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.
2. Truong LD, Barrios R, Adrogue HE, et al. Acute antibody-mediated rejection of renal transplant: pathogenetic and diagnostic considerations. Arch Pathol Lab Med 2007; 131: 1200.
3. Racusen LC, Haas M. Antibody-mediated rejection in renal allografts: lessons from pathology. Clin J Am Soc Nephrol 2006; 1: 415.
4. Hirohashi T, Chase CM, Della Pelle P, et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant 2012; 12: 313.
5. Hirohashi T, Uehara S, Chase CM, et al. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010; 10: 510.
6. Lee CY, Lotfi-Emran S, Erdinc M, et al. The involvement of FcR mechanisms in antibody-mediated rejection. Transplantation 2007; 84: 1324.
7. Toyoda M, Pao A, Vo A, et al. Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization. Transpl Immunol 2010; 22: 121.
8. Toyoda M, Ge S, Pao A, et al. Cellular allo reactivity against paternal HLA antigens in normal multiparous females as detected by intracellular cytokine flow cytometry remains elevated over years despite diminution of anti-HLA antibody levels. Transpl Immunol 2010; 23: 133.
9. Toyoda M, Ge S, Suviolahti E, et al. IFNgamma production by NK cells from HLA-sensitized patients after in vitro exposure to allo-antigens. Transpl Immunol 2012; 26: 107.
10. Samaniego M, Becker BN, Djamali A. Drug insight: maintenance immunosuppression in kidney transplant recipients. Nat Clin Pract Nephrol 2006; 2: 688.
11. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294: 15.
12. Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001; 19: 197.
13. Paust S, von Andrian UH. Natural killer cell memory. Nat Immunol 2011; 12: 500.
14. O'Leary JG, Goodarzi M, Drayton DL, et al. T cell-and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006; 7: 507.
15. Beilke JN, Gill RG. Frontiers in nephrology: the varied faces of natural killer cells in transplantationVcontributions to both allograft immunity and tolerance. J Am Soc Nephrol 2007; 18: 2262.
16. LaRosa DF, Rahman AH, Turka LA. The innate immune system in allograft rejection and tolerance. J Immunol 2007; 178: 7503.
17. Hidalgo LG, Sellares J, Sis B, et al. Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant 2012; 12: 1180.
18. Prendergast MB, Gaston RS. Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol 2010; 5: 1305.
19. Sellares J, Reeve J, Loupy A, et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant 2013; 13: 971.
20. Sellares J, Reeve J, Kamulski K, et al. A molecular diagnostic test for antibody-mediated rejection in kidney transplant biopsies. Am J Transplant 2012; 12: 185.
21. Loupy A, Sellares J, Hidalgo LG, et al. NK transcript burden is associated with disease activity in type I ABMR. Am J Transplant. 2012; 12: 79.
22. Kurosaki T, Gander I, Ravetch JV. A subunit common to an IgG Fc receptor and the T-cell receptor mediates assembly through different interactions. P Natl Acad Sci USA 1991; 88: 3837.
23. Anderson P, Caligiuri M, Ritz J, et al. CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex. Nature 1989; 341: 159.
24. Lanier LL, Yu G, Phillips JH. Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 1989; 342: 803.
25. Zoller KE, MacNeil IA, Brugge JS. Protein tyrosine kinases Syk and ZAP-70 display distinct requirements for Src family kinases in immune response receptor signal transduction. J Immunol 1997; 158: 1650.
26. Kagi D, Ledermann B, Burki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994; 369: 31.
27. Sica A, Dorman L, Viggiano V, et al. Interaction of NF-kappa B and NFAT with the interferon-gamma promoter. J Biol Chem 1997; 272: 30412.
28. Cheng CM, Kong XF, Wang HZ, et al. Trihydrophobin 1 interacts with PAK1 and regulates ERK/MAPK activation and cell migration. J Biol Chem 2009; 284: 8786.
29. Morteau O, Blundell S, Chakera A, et al. Renal transplant immuno-suppression impairs natural killer cell function in vitro and in vivo. PLoS One 2010; 5: e13294.
30. Neudoerfl C, Mueller BJ, Blume C, et al. The peripheral NK cell repertoire after kidney transplantation is modulated by different immu-nosuppressive drugs. Front Immunol 2013; 4: 46.
31. Stellato C. Post-transcriptional and nongenomic effects of glucocor-ticoids. Proc Am Thorac Soc 2004; 1: 255.
32. Bush KA, Krukowski K, Eddy JL, et al. Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules. Cell Immunol 2012; 275: 80.
33. Nair MPN, Schwartz SA. Immunomodulatory effects of corticoste-roids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes. J Immunol 1984; 132: 2876.
34. Nieto Y. Pharmacodynamics of high-dose chemotherapy. Curr Drug Metab 2001; 2: 53.
35. Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of the evidence. Kidney Int 2001; 59: 3.
36. Abraham RT. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr Opin Immunol 1998; 10: 330.
37. Wai LE, Fujiki M, Takeda S, et al. Rapamycin, but not cyclosporine or FK506, alters natural killer cell function. Transplantation 2008; 85: 145.
38. Gourlay WA, Chambers WH, Monaco AP, et al. Importance of natural killer cells in the rejection of hamster skin xenografts. Transplantation 1998; 65: 727.
39. Srinivas TR, Meier-Kriesche HU, Kaplan B. Pharmacokinetic principles of immunosuppressive drugs. Am J Transplant 2005; 5: 207.
40. Devyatko E, Zuckerman A, Bohdjalian A, et al. Activation of the pu-rine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetil. Transplantation 2006; 82: 113.
41. Devyatko E, Dunkler D, Bohdjalian A, et al. Lymphocyte activation and correlation with IMPDH activity under therapy with myco-phenolate mofetil. Clin Chim Acta 2008; 394: 67.
42. Vacher-Coponat H, Brunet C, Moal V, et al. Tacrolimus/mycophenolate killer lymphocyte recon kidney transplant mofetil improved natural killer lymphocyte reconstitution one year after by reference to cyclosporine/ azathioprine. Transplantation 2006; 82: 558.
43. Halloran PF, de Freitas DG, Einecke G, et al. The molecular phenotype of kidney transplants. Am J Transplant 2010; 10: 2215.
44. Loupy A, Hill GS, Jordan SC. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol 2012; 8: 348.
45. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Tr a n s-plantation 2010; 90: 68.